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Angiogenesis, also known as new blood vessel formation, is regulated coordinately with other tissue differentiation events during limb
development. Although vascular endothelial cell growth factor (VEGF) is important in the regulation of angiogenesis, chondrogenesis and
osteogenesis during limb development, the role of other angiogenic factors is not well understood. Sphingosine 1-phosphate, a platelet-
derived lipid mediator, regulates angiogenesis and vascular maturation via its action on the G-protein-coupled receptor S1P1 (also known
as EDG-1). In addition to vascular defects, abnormal limb development was also observed in S1p1
/ mice. Here we show that strong
induction of S1P1 expression is observed in the blood vessels and the interdigital mesenchymal cells during limb development. Deletion of
S1P1 results in aberrant chondrocyte condensation and defective digit morphogenesis. Interestingly, the vasculature in the S1p1
/ limbs
was hyperplastic and morphologically altered. In addition, the hypoxia inducible factor (HIF)-1a and its response gene VEGF were
induced in S1p1
/ limbs. However, aberrant regulation of HIF-1a and VEGF were not observed in embryonic fibroblasts derived from
S1p1
/ mice, suggesting a non-cell autonomous effect of S1P1 on VEGF expression. Indeed, similar limb defects were observed in
endothelium-specific S1P1 null mice in vivo. These data suggest that the function of S1P1 in the developing vasculature is essential for
proper limb development.
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Cartilage formation is one of the early morphogenetic
processes during embryonic development and involves a
series of strictly coordinated events (Olsen et al., 2000).
During limb development, cells from the lateral plate meso-
derm migrate to the future bone areas and undergo precarti-
laginous condensation. Mesenchymal cells of the limb bud
are differentiated into chondrocytes or fibroblasts whereas0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.01.001
Abbreviations: S1P, sphingosine 1-phosphate; VEGF, vascular endo-
thelial growth factor; HIF-1a, hypoxia inducible factor-alpha; ECM,
extracellular matrix; VSMC, vascular smooth muscle cells; PDGF, platelet-
derived growth factor; FGF, fibroblast growth factor; PECAM, platelet
endothelial cell adhesion molecule; MEF, mouse embryonic fibroblast;
GLUT, glucose transporter.
* Corresponding author. Center for Vascular Biology, MC3501,
Department of Cell Biology, University of Connecticut Health Center, 263
Farmington Avenue, Farmington, CT 06030-3401. Fax: +1-860-679-1201.
E-mail address: hla@nso2.uchc.edu (T. Hla).undifferentiated mesenchymal cells produce extracellular
matrix (ECM). Chondrogenic cells become demarcated by
ECM and acquire the characteristic limb skeletal pattern by
undergoing a series of bifurcations and segmentation pro-
cesses. Cartilage formation is then followed by endochondral
ossification, during which chondrocytes in the avascular
cartilage differentiate into hypertrophic cartilage, which is
vascularized by the neighboring angiogenic precursor cells.
Angiogenesis of the cartilage primordium occurs concomi-
tantly with invasion of osteoblasts and bone formation
(ossification). Whereas chondrocytes of the avascular carti-
lage produce inhibitors of angiogenesis, hypertrophic chon-
drocytes produce angiogenic stimulators that initiate
vascularization, indicating the requirement for precise regu-
lation of angiogenesis during chondrogenesis (Gerber et al.,
1999).
During development, the vascular system forms by vas-
culogenesis (de novo vessel formation) and angiogenesis
(vessel formation from preexisting vessels) (Carmeliet,
2003; Jain, 2003). In fact, the cardiovascular system is the
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embryo and supply nutrients and oxygen to all tissues.
Vascular development requires processes such as vessel
formation, patterning, pruning, remodeling and maturation.
Failure in any process during vascular development leads to
embryonic lethality. Immature vessels formed by vasculo-
genesis and angiogenesis must be stabilized by mural cells,
such as pericytes and vascular smooth muscle cells (VSMC)
(Jain, 2003). During vessel stabilization, mural cells are
recruited to invest the nascent endothelial tubes, thereby
providing stability in the developing cardiovascular system
with increasing demands and stresses.
Recent studies have made significant progress in defining
the signaling pathways required for the recruitment and the
differentiation of mural cells during vessel maturation. A
number of signaling molecules, including platelet-derived
growth factor (PDGF)-BB/PDGF-receptor-h, Smad5, endo-
glin and angiopoietin-1 have been identified as critical
regulators of vessel maturation (Allende and Proia, 2002;
Jain, 2003). Targeted disruption of the genes encoding these
receptors and ligands in mice has been particularly informa-
tive in defining their roles. For example, PDGF-BB is
essential for the recruitment of mesenchymal mural cell
precursors expressing PDGF receptor-h to vessel walls
(Leveen et al., 1994). Disruption of the PDGF-B or PDGF
receptor-h genes in mice leads to microvasculature aneur-
ysms, lethal hemorrhaging and edema in the perinatal stage
due to a lack of pericytes (Hellstrom et al., 2001). Such
signaling systems may also be important in vessel develop-
ment/growth in the adult. For example, inhibition of vessel
stabilization in mice by inhibiting PDGF-receptor-h together
with the VEGF receptor resulted in additive inhibition of
tumor angiogenesis and growth (Bergers et al., 2003). Thus,
signaling systems for vessel stabilization are of importance
not only in embryogenesis but also in adult physiology and
pathology.
Our laboratory has defined the platelet-derived bioactive
lipid sphingosine-1-phosphate (S1P) as a regulator of an-
giogenesis, vascular development and homeostasis (Hla,
2003; Hla et al., 2001). We originally cloned the S1P1/
EDG-1 (Endothelial Differentiation Gene-1) cDNA and
showed that it encodes a high-affinity receptor for S1P
(Hla and Maciag, 1990; Lee et al., 1998). In models of
angiogenesis and vascular maturation in adult mice, S1P
synergized with polypeptide growth factors such as vascular
endothelial growth factor (VEGF) and fibroblast growth
factor (FGF) in the formation of mature vascular structures
(Lee et al., 1999). Deletion of the S1p1 gene in the mouse
resulted in embryonic lethality due to defects in vascular
stabilization (Liu et al., 2000), where defective mural cell
investment to endothelial cells was observed. Interestingly,
S1p1
/ embryo also showed defective limb development;
however, this was not emphasized in that study and detailed
characterization of how S1P regulates limb development
was not studied. In this study, we further characterized the
underlying mechanism of how S1P1 regulates limb devel-opment. Our data suggest S1P1-regulated mechanisms in the
developing limb bud in the coordination of angiogenesis
and chondrogenesis.Materials and methods
Animals
S1p1
/LacZ and S1p1-conditional mutant embryos were
generated and genotyped as previously described (Allende
et al., 2003; Liu et al., 2000). To obtain endothelial specific
S1p1 knockout (S1p1 loxP/KoTie2-Cre) and control litter-
mates (S1p1 loxP/KO, S1p1 loxP/WT Tie2-Cre or S1p1 loxP/
WT), S1p1 loxP/loxP mice were bred with S1p1 WT/KO
mice expressing Cre recombinase under the control of the
EC-specific promoter Tie2 (Allende et al., 2003).
b-galactosidase (LacZ) staining of embryos
Embryos were isolated in cold phosphate-buffered saline
(PBS) and fixed in 0.2% glutaraldehyde and 1.5% parafor-
maldehyde in PBS, pH 7.4, at room temperature for 30 min,
then washed in PBS. Staining was performed at 37jC in
0.02% X-gal, 5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6, 2 mM
MgCl2 in PBS overnight. The stained embryos were washed,
postfixed in 4% paraformaldehyde, embedded in paraffin,
and sectioned at 5 Am.
Whole-mount embryo immunostaining
Embryos were fixed in 4% paraformaldehyde in PBS at
4jC overnight, dehydrated through a methanol series and
stored in 100% methanol at 20jC. The embryos were
then bleached in 6% hydrogen peroxide/methanol for 1 h at
room temperature and hydrated through a methanol series
to 0.1% Tween 20/PBS (PBST). Hydrated embryos were
incubated twice for 1 h in 4% BSA in PBST. The embryos
were incubated with anti-CD31 antibodies, diluted 1:200 in
10% goat serum and 4% BSA in PBST at 4jC overnight.
Embryos were washed with 4% BSA in PBST and
incubated with peroxidase-conjugated goat anti-rat IgG in
10% goat serum and 4% BSA in PBST at 4jC overnight.
DAB/hydrogen peroxide was used for visualization.
Alcian blue staining
Embryos were fixed in Bouin’s solution (75% picric
acid, 10% formaldehyde, 5% acetic acid) for 2 h.
Embryos were then washed six to eight times in wash
buffer (0.1% NH4OH, 70% ethanol) until noncartilagi-
nous tissues were white and equilibrated in 5% acetic
acid twice for 1 h. Embryos were stained in 0.05%
Alcian Blue 8XG in 5% acetic acid and rinsed twice
for 2 h with 5% acetic acid. Stained embryos were
cleared with methanol.
Fig. 1. S1P1 expression in the developing limbs. E11.5 (A), E12.5 (B, C,
D), E13.5 (E) and E15.5 (F, G, H) S1p1
+/LacZ embryos were lacZ-stained.
Longitudinal sections were counterstained with anti-CD31 antibody (D, H).
(B, F) Dorsal view. (C, E, G) Ventral view. Arrowheads and arrows indicate
blood vessels and apoptotic areas, respectively.
Fig. 2. Defective limb development in S1p1
/ embryos. Limbs from
S1p1
/ (A, C, E, G) and wild-type (B, D, F, H) embryos at E12.5 were fixed,
sectioned and stained with H&E (C, D). (A, B) Brightfield image. Cartilage
formation was detected by Alcian blue staining (E, F). Arrowheads indicate
cartilage primordia in the area where the digits will form. Asterisks indicate
corresponding regions in S1p1
/ limbs. Limb vasculature was visualized by
whole-mount staining with anti-CD31 antibody (G, H). Note the high
density of dilated blood vessels in the S1p1
/ limb.
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Total RNA from limbs of different developmental stages
of mouse embryos was isolated using the RNeasy kitk
(Qiagen Inc, Valencia, CA), as described by the manufac-
turer. Four micrograms of total RNA was subjected to
Northern hybridization using oligonucleotide probes spe-
cific to the VEGF 3VUTR at standard conditions. For
hypoxic studies, mouse embryonic fibroblasts (MEFs) were
incubated in hypoxic chamber gassed with 2% O2–5%
CO2 and balanced with N2 at 37jC for 16 h. For S1P
stimulation, cells were serum-starved for 16 h and treated
with 100 nM of S1P for 6 h. Ten micrograms of total RNA
was used.
Western blot analysis
Limbs from E12.5 embryos were isolated and homoge-
nized in hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mMMgCl2, 10 mM KCl, 0.5 mM DTT, 0.5% NP-40, protease
inhibitors cocktail) by using the Dounce homogenizer.
Homogenate was centrifuged at 1500  g for 5 min, the
pellet was washed with hypotonic buffer, resuspended in
high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 0.42
M KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT,
protease inhibitors cocktail) and incubated for 20 min on ice.
Nuclear proteins were obtained by centrifugation at 15,000
 g for 20 min. Twenty micrograms of nuclear protein was
subjected to gel electrophoresis and transferred to nitrocel-
lulose membrane. HIF-1a was detected by monoclonal HIF-
1a antibody (Novus Biological). Nuclear fraction was con-
firmed by immunoblot with the antibody for nuclear protein,
lamin B1 (Zymed Laboratories Inc.).
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Expression of S1P1 during limb development
Previous studies have defined the expression of S1P1
during midgestation mouse development by analysis of
reporter gene expression (h-galactosidase) in S1p1
+/ mice
(Liu et al., 2000). In these studies, expression of S1P1 was
found in the developing vasculature, heart and forebrain.
However, a more comprehensive analysis of expression in
different stages of embryonic development has not been
reported. We noticed that S1P1 expression was more wide-
spread at later stages of embryonic development (data not
shown). In particular, S1P1 expression was induced in the
developing limb at E11.5 (Fig. 1A). At E12.5, expression
was more prominent in the blood vessels and interdigital
areas (Figs. 1B,C). Immunohistochemical staining of limb
sections with the endothelial cell marker PECAM/CD31 on
X-gal stained tissues showed that S1P1 was expressed in
vascular cells as well as limb mesenchymal cells (Figs.
1D,H). Most PECAM/CD31-positive endothelial cells were
also positive for S1P1. At later stages of development
(E13.5–15.5), this pattern was more prominent in the tips
of digits and interdigital areas (Figs. 1E–G). These data
suggest that S1P1 is strongly expressed in the areas of the
developing limb undergoing apoptosis, tissue remodeling
and vascular development.
Defective limb development in S1p1
/ embryos
To gain further insights into the functional role of S1P1 in
limb development, developing limbs from wild-type and
S1p1
/ embryos were analyzed. As shown in Fig. 2, S1p1
/
limbs showed major developmental defects. Even in early
stages (E10.5–11.5) when the embryos were viable (with a
heartbeat), the limbs appear short (data not shown). AtFig. 3. Hypoxia and VEGF induction in S1p1
/ limbs. VEGF RNA level was d
to VEGF 3VUTR. Four micrograms of total RNA from limbs of null (/), het
(B) were used. MEFs were incubated in hypoxic chamber for 16 h for hypoxia
100 nM of S1P for 6 h. (C) The protein level of HIF1-a was determined in nuc
(+/+) embryonic limbs. Nuclear fractionation was confirmed by nuclear marker
hypoxia.E12.5 days of development, limb morphogenesis was aber-
rant as interdigital sculpting was absent (Figs. 2A,B).
Histological analysis showed that chondrocyte condensa-
tion, which is required for digit formation, appeared to be
impaired in S1p1
/ limbs (Fig. 2C vs. D). Whole-mount
Alcian blue staining showed the normal development of
stylopod and zeugopod but not autopod formation (Fig. 2E
vs. F, asterisks). In addition to defective digit formation,
knockout limbs were hypervascularized with dilated vessels
(Fig. 2G vs. H). These data suggest that lack of S1P1 results
in limb morphogenetic defects and hypervascularity during
development.
Non-cell-autonomous effect of S1P1 on VEGF induction
It is known that S1p1
/ mice develop a vascular stabi-
lization defect, resulting in vascular system failure and
hemorrhage. This is apparent at E12.5 days of development,
and by E15.5 100% of the embryos show lethal hemorrhage.
To determine the molecular basis of the hypervascular
defect in the limbs of S1p1
/ mice, we determined the
expression level of the critical angiogenic factor, VEGF. As
shown in Fig. 3A, VEGF levels were strongly induced in the
limbs of S1p1
/ mice, suggesting that this may be an
important event in the induction of hypervascular response.
To test if VEGF induction in S1p1
/ mice is caused by cell-
autonomous signaling of S1P1, the expression levels of
VEGF in wild-type and S1p1
/ MEF were compared by
Northern blot analysis (Fig. 3B). VEGF expression in cells
of both genotypes was comparable and was unaffected by
S1P stimulation. However, hypoxia potently induced VEGF
expression in both genotypes, suggesting that S1P1 signal-
ing per se in a cell-autonomous manner does not regulate
VEGF expression. Rather, the enhanced VEGF expression
occurs in vivo, most likely due to a systemic effect brought
about by S1p1 gene deletion.etermined by Northern hybridization using oligonucleotide probes specific
erozygous (+/) and wild type (+/+) embryos (A) and 10 Ag from MEFs
. For S1P stimulation, cells were serum-starved for 16 h and treated with
lear proteins isolated from null (/), heterozygous (+/) and wild type
protein, lamin B1. WT, S1p1
+/+ MEF; KO, S1p1
/ MEF; N, normoxia; H,
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VEGF expression is directly induced by tissue hypoxia
(Carmeliet, 2003). It is possible that in the growing periph-
eral tissue such as the developing limb, tissue hypoxia could
be an important factor in the regulation of VEGF expression
and angiogenesis. Indeed, the vascular stabilization defect in
S1p1
/ mice (Liu et al., 2000) could lead to exacerbated
hypoxia. To test if hypoxia is a dominant inducer of VEGF
in S1p1
/ limbs, the level of hypoxia inducible factor (HIF)-
1a polypeptide was compared. As shown in Fig. 3C, S1p1
/
limbs showed much higher level of HIF-1a, suggesting that
hypoxia upregulates VEGF expression, which leads to
abnormal hypervascularization.
Defective limb development caused by the
endothelium-specific loss of S1P1
Although severe hypoxia is present in S1P1 null limbs,
resulting in enhanced VEGF expression, hypervasculariza-
tion and limb defects, it is formally possible that the
function of S1P1 in nonvascular tissues of the developing
limb, for example, the interdigital area, contributes to the
observed phenotype. To test if vascular or nonvascular
function of S1P1 is responsible for the limb developmental
defects, endothelial cell-specific S1p1
/ embryos were
examined. Interestingly, endothelial cell-specific S1p1
/
mice also showed the same phenotypic defects in limb
development as S1P1 null embryos (Fig. 4). Compared
with control littermate (Figs. 4A,C), knockout limbs
showed defective chondrocyte condensation and hemor-
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and photographed. Embryonic limbs were sectioned and stained with H&E.rhage (Figs. 4B,D). In addition, edema and dilated abnor-
mal vasculature were also observed in some limbs (data
not shown). These data indicate that loss of S1P1 in
endothelial cell abrogates normal limb development and
support the notion that function of the receptor in the
vasculature is primarily responsible for the observed
defects in limb development.Discussion
S1P1 is known to be important in endothelial cell
survival, migration, and morphogenesis (Hla et al., 2000,
2001). During embryonic development, intense expression
of S1P1 is detected in cardiovascular system, including the
heart, dorsal aorta, intersomitic arteries and capillaries (Liu
et al., 2000). In accordance with this expression pattern,
S1p1
/ embryos show defects in the developing vascular
system, especially in the process of vascular stabilization.
The phenotype of S1p1
/ mice suggests a pivotal role of
S1P1 in embryonic vascular development. Immature vascu-
lature is inefficient in the delivery of nutrients and oxygen to
tissues, ultimately resulting in hypoxia. To meet the demand
of oxygen, tissues in hypoxic environment produce angio-
genic factors to stimulate blood vessel formation. A growing
number of studies have emphasized the importance of HIF
family of transcription factors on the regulation of expres-
sion of angiogenic factors (Pugh and Ratcliffe, 2003). Under
hypoxic conditions, HIF-1a stabilization by the oxygen
sensing machinery results in the increased level of HIF-
1a, which induces the transcription of target genes, such asTie2-Cre (B, D) and control littermate (A, C) embryos at E12.5 were isolated
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and Ratcliffe, 2003). Significantly, high level of HIF-1a in
S1p1
/ limbs strongly suggests the presence of severe
hypoxia in this tissue. Strong induction of VEGF mRNA
and hypervascularization, therefore, may be caused by
hypoxia in S1P1 null limbs. However, hypoxia strongly
induced VEGF expression in wild type and S1p1
/ MEFs
while S1P stimulation had no effect on VEGF expression
level. These data suggest that impaired digit formation may
occur secondarily to the vascular defects. This notion is
strongly supported by the fact that endothelium-specific
knockout of the S1P1 receptor phenocopies the global
knockout of S1p1
/ (Allende et al., 2003).
It has been shown that angiogenic factors inhibited
chondrocyte maturation, which is an important step in bone
formation. Indeed, vascular regression is required for chon-
drogenesis in the developing limb of avian embryos (Yin
and Pacifici, 2001). It is therefore likely that defective
vascular development induced by lack of S1P1 caused
hypoxia, leading to enhanced VEGF expression and hyper-
vascularization, which ultimately disturbs the limb morpho-
genesis and patterning. In addition, signaling between
endothelial cells and surrounding tissues might also con-
tribute to the phenotypic defects. Indeed, recent studies
show that developing endothelial cells provide instructive
cues to allow proper differentiation of the endoderm into
pancreas and liver (Cleaver and Melton, 2003).
Interestingly, S1P1 is expressed in the endothelial cells
and interdigital mesenchyme, suggesting the possible role in
angiogenesis and remodeling in the developing limb. As
limb development ensues, expression of S1P1 is also ob-
served in the tips of digits where cells are removed by
apoptosis. Programmed cell death has long been recognized
as an important mechanism of normal embryonic develop-
ment. In the developing limb, massive programmed cell
death plays a critical role in controlling the amount of
mesodermal tissue, sculpting overall limb shape and defin-
ing the digits. Cell death in the limb bud is regulated by
several factors, including environmental conditions and
interactions between epithelium and mesenchyme (Chen
and Zhao, 1998). Removing the ectoderm overlying the
interdigital area inhibited cell death, leading to the ectopic
cartilage formation in the subjacent mesenchyme. While it is
highly likely that S1P1 signaling plays a role in tissue
remodeling, further analysis of this function is not possible
now since the profound vascular defects masked the out-
come in the interdigital areas of S1p1
/ limb.
Limb defects in the S1p1
/ embryo are dramatic, which
have not been reported in other angiogenic factor null mice.
Only VEGF knockouts show a significant growth plate
phenotype, whereas deletion of other angiogenic factors,
including TGF-h1, -h3 and endostatin, do not result in
phenotypic changes in the growth plate (Zelzer et al., 2002).
Our finding that S1P1 in endothelial cells is critical for
proper limb development underscores the importance of this
lipid mediator in development.This study shows that sphingolipid signaling in the
vasculature plays a profound role in the development of
the limb tissue. It also points out that abnormal vascular
development can induce dramatic changes in surrounding
tissues. These mechanistic findings may have implica-
tions in the function of S1P1 in adult physiology and
pathology. During wound healing and tumor develop-
ment, S1P/S1P1 signaling may be important in angiogen-
esis and vascular maturation and thereby influence the
growth of the juxtaposed tissues, such as the healing
wound or the developing tumor. Such mechanisms should
be considered in novel approaches to develop pharmaco-
logical tools to modulate the S1P1 G-protein-coupled
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